Crossref
Refractory bullous pemphigoid during treatment with pembrolizumab in the first-line treatment of advanced non-small cell lung cancer
Forum Dermatologicum · 2024
DOI: 10.5603/fd.100000 ↗Kurz gefasst
Fachartikel in der Zeitschrift Forum Dermatologicum, 2024. Verfasst von Renata Olech und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Olech, R., Rychlik-Grabowska, M., & Mańdziuk, S. (2024). Refractory bullous pemphigoid during treatment with pembrolizumab in the first-line treatment of advanced non-small cell lung cancer. Forum Dermatologicum. https://doi.org/10.5603/fd.100000
Vancouver
Olech R, Rychlik-Grabowska M, Mańdziuk S. Refractory bullous pemphigoid during treatment with pembrolizumab in the first-line treatment of advanced non-small cell lung cancer. Forum Dermatologicum. 2024. doi:10.5603/fd.100000
BibTeX
@article{Olech2024,
author = {Olech, Renata and Rychlik-Grabowska, Monika and Mańdziuk, Sławomir},
title = {Refractory bullous pemphigoid during treatment with pembrolizumab in the first-line treatment of advanced non-small cell lung cancer},
journal = {Forum Dermatologicum},
year = {2024},
doi = {10.5603/fd.100000}
}
EUVIMED